argenx Banner Image


  • Ticker ARGX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
argenx Logo Image
  • 501-1000 Employees
  • Based in Boston, Massachusetts
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-onlyMore approved neonatal Fc receptor (FcRn) blocker in the U.S., the EU, Japan and the UK.
4.8 / 5.0 (76)

argenx reports have an aggregate usefulness score of 4.8 based on 76 reviews.


Most Recent Annual Report

MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

argenx Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!